Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor

被引:20
|
作者
Emani, Sirisha [1 ]
Ramlawi, Basel [1 ]
Sodha, Neel R. [1 ]
Li, Jian [1 ]
Bianchi, Cesario [1 ]
Sellke, Frank W. [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
来源
关键词
FACTOR-I; VEGF; ACTIVATION; HYPOXIA; PROLIFERATION; ANGIOGENESIS; KINASE; CELLS;
D O I
10.1016/j.jtcvs.2008.12.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several inflammatory mediators such as vascular endothelial growth factor and hepatocyte growth factor are known to play a critical role in the regulation of vascular permeability and angiogenesis. We studied the serum levels of growth factors and gene expression profiles of genes involved in growth factor signaling in the peripheral blood of patients with and patients without diabetes following cardiopulmonary bypass and cardioplegic arrest. Methods: Serum and total RNA were obtained from the blood samples collected from patients with diabetes and matched patients without diabetes (n = 7 patients each) who had coronary artery bypass graft before and 6 hours and 4 days after cardiopulmonary bypass/cardioplegic arrest. The cytokine panel, consisting of growth factors such as vascular endothelial growth factor, hepatocyte growth factor, fibroblast growth factor, and epidermal growth factor, was quantified in patients with diabetes and patients without diabetes before and 6 hours and 4 days post-cardiopulmonary bypass/cardioplegic arrest using multiplex cytokine quantification system. cDNA microarray analysis was performed and fold-change was calculated. Results: Length of hospitalization (10 vs 6 days; P = .04) and weight gain (5 vs 2.5 kg; P = .001) were significantly greater for patients with diabetes compared with patients without diabetes. The serum levels of vascular endothelial growth factor and hepatocyte growth factor were significantly elevated in patients with diabetes when compared with patients without diabetes before versus 6 hours post-cardiopulmonary bypass/cardioplegic arrest. In addition, significantly elevated mRNA expression of hypoxia-inducible factor-1 alpha, cyclic adenosine monophosphate response element binding protein, and E1A binding protein p300 (more than twofold) was observed 4 days post-cardiopulmonary bypass/cardioplegic arrest exclusively in patients with diabetes. Conclusions: The differential profile of gene and protein expression of growth factors and their related genes in patients with diabetes and patients without diabetes could be associated with increased edema and weight gain in patients with diabetes after cardiopulmonary bypass/cardioplegic arrest.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 50 条
  • [21] Gestational diabetes mellitus is associated with increased pro-migratory activation of vascular endothelial growth factor receptor 2 and reduced expression of vascular endothelial growth factor receptor 1
    Troncoso, Felipe
    Acurio, Jesenia
    Herlitz, Kurt
    Aguayo, Claudio
    Bertoglia, Patricio
    Guzman-Gutierrez, Enrique
    Loyola, Marco
    Gonzalez, Marcelo
    Rezgaoui, Meriem
    Desoye, Gernot
    Escudero, Carlos
    PLOS ONE, 2017, 12 (08):
  • [22] Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma
    Suzuki, K
    Hayashi, N
    Miyamoto, Y
    Yamamoto, M
    Ohkawa, K
    Ito, Y
    Sasaki, Y
    Yamaguchi, Y
    Nakase, H
    Noda, K
    Enomoto, N
    Arai, K
    Yamada, Y
    Yoshihara, H
    Tujimura, T
    Kawano, K
    Yoshikawa, K
    Kamada, T
    CANCER RESEARCH, 1996, 56 (13) : 3004 - 3009
  • [23] Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain
    Papavassiliou, E
    Gogate, N
    Proescholdt, M
    Heiss, JD
    Walbridge, S
    Edwards, NA
    Oldfield, EH
    Merrill, MJ
    JOURNAL OF NEUROSCIENCE RESEARCH, 1997, 49 (04) : 451 - 460
  • [24] Increased concentration of vascular endothelial growth factor vascular permeability factor in cyst fluid of enlarging and recurrent thyroid nodules
    Sato, K
    Miyakawa, M
    Onoda, N
    Demura, H
    Yamashita, T
    Miura, M
    Kasajima, T
    Yamazaki, K
    Obara, T
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06): : 1968 - 1973
  • [25] Increased plasma vascular endothelial growth factor levels in patients with angiodysplasia
    Fujita, H
    Momoi, M
    Chuganji, Y
    Tomiyama, J
    JOURNAL OF INTERNAL MEDICINE, 2000, 248 (03) : 268 - 269
  • [26] Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome
    Thickett, DR
    Armstrong, L
    Christie, SJ
    Millar, AB
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (09) : 1601 - 1605
  • [27] Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?
    Peng Xuebing
    Li TinChiu
    Xia Enlan
    Luo Jing
    Huang Xiaowu
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 159 (01) : 198 - 203
  • [28] INCREASED EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IN BULLOUS PEMPHIGOID, DERMATITIS-HERPETIFORMIS, AND ERYTHEMA MULTIFORME
    BROWN, LF
    HARRIST, TJ
    YEO, KT
    STAHLEBACKDAHL, M
    JACKMAN, RW
    BERSE, B
    TOGNAZZI, K
    DVORAK, HF
    DETMAR, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (05) : 744 - 749
  • [29] Increased local vascular endothelial growth factor expression associated with antitumor activity of proteasome inhibitor
    T. Stokłosa
    J. Goła¸b
    C. Wójcik
    P. Włodarski
    A. Jalili
    P. Januszko
    A. Giermasz
    G. M. Wilczyński
    E. Pleban
    M. Marczak
    S. Wilk
    M. Jakóbisiak
    Apoptosis, 2004, 9 : 193 - 204
  • [30] Increased local vascular endothelial growth factor expression associated with antitumor activity of proteasome inhibitor
    Stoklosa, T
    Golab, J
    Wójcik, C
    Wlodarski, P
    Jalili, A
    Januszko, P
    Giermasz, A
    Wilczynski, GM
    Pleban, E
    Marczak, M
    Wilk, S
    Jakóbisiak, M
    APOPTOSIS, 2004, 9 (02) : 193 - 204